Sulfadoxine + Pyrimethamine (SP) – tablets

Sulfadoxine + Pyrimethamine (SP) – tablets

Form: Tablet

Strength: 500 mg sulfadoxine + 25 mg pyrimethamine; 500 mg + 75 mg

Reference Brands: Generic formulations

Category: Medical Aid

Sulfadoxine + Pyrimethamine (SP) tablets are approved for malaria treatment and prophylaxis in the EU and US, mainly in endemic regions. In the EU, brands like Fansidar are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, approval is limited; primarily used in travel medicine and imported cases, with no specific brand approval. Both regions require detailed dossiers including clinical trial data, quality assurance, and pharmacovigilance plans for approval and safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for sulfadoxine/pyrimethamine, ensuring adherence to European and US standards for safe, effective malaria therapy.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Chlorhexidine Solutions

Strength: 0.12% or 2%

Form: Solutions for disinfection

Reference Brands: Peridex, Periogard(US)

View Details Get Enquiry
Hydrochlorothiazide Tablets

Strength: 12.5 mg, 25 mg, 50 mg

Form: Tablet

Reference Brands: Microzide, HydroDiuril(US)

View Details Get Enquiry
Lisinopril Tablets

Strength: 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg

Form: Tablet

Reference Brands: Prinivil, Zestril(US & EU)

View Details Get Enquiry
Enalapril tablets

Strength: 2.5 mg, 5 mg, 10 mg, 20 mg

Form: Tablet

Reference Brands: Vasotec(US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.